Newbury Pharmaceuticals AB
Develops specialty prescription drugs for Scandinavia in oncology, rare diseases & neurology.
NEWBRY | ST
Overview
Corporate Details
- ISIN(s):
- SE0015244884
- LEI:
- 549300F7XHU3I8CWL373
- Country:
- Sweden
- Address:
- Medicon Village, 223 81 Lund
- Website:
- https://www.newburypharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Newbury Pharmaceuticals AB is a rapidly growing hybrid pharmaceutical company specializing in specialty prescription drugs, innovation, and branded products. The company focuses on the Scandinavian market, building a pipeline of proprietary and licensed products. Its primary therapeutic areas of interest include oncology, rare diseases, and neurology. Newbury Pharmaceuticals positions itself as a local champion and an alternative partner to larger multinational pharmaceutical corporations in the region.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-10-05 13:14 |
Regulatory News Service
Edison Investment Research Limited: Edison issues outlook on NeuroVive Pharmace…
|
English | 10.7 KB | ||
| 2017-06-29 13:30 |
Report Publication Announcement
EQS-News: Edison Investment Research Limited: Edison issues initiation on Neuro…
|
English | 11.1 KB |
Automate Your Workflow. Get a real-time feed of all Newbury Pharmaceuticals AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Newbury Pharmaceuticals AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-29 | Johan Strömqvist | Other | Sell | 13,564 | 40,692.00 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Sell | 10,400 | 30,888.00 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Buy | 10,200 | 30,804.00 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Buy | 5,000 | 15,570.50 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Buy | 5,000 | 15,200.00 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Sell | 2,436 | 7,332.36 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Sell | 100 | 305.00 SEK |
| 2024-08-03 | Andreas Hedskog | Other | Buy | 200,000 | 178,000.00 SEK |
| 2024-08-03 | Andreas Hedskog | Other | Other | 200,000 | N/A |
| 2024-01-22 | Alsakali Equity AB | Other | Buy | 4,000 | 18,920.00 SEK |
